Tesamorelin (Injectable) in Ohio
Doctor-prescribed Tesamorelin (Injectable) for Ohio residents. Reviewed by licensed Ohio physicians, compounded at FDA-registered pharmacies, and shipped to your door.
All-in monthly price
No membership fee · this is the full price · free shipping · avg 4-week supply
Add in-depth bloodwork
Optional — add a physician-reviewed at-home blood panel to your plan.
Your sex-hormone baseline plus the safety markers that matter on therapy — blood counts, liver and kidney function — from one painless upper-arm device. Matched to your sex (PSA for men; progesterone & FSH for women). No needle, no clinic, physician-reviewed.
This treatment requires licensed provider review and approval. Treatment is not guaranteed. If prescribed, medication is fulfilled by a licensed U.S. pharmacy where permitted by law. Compounded medications are not FDA-approved or FDA-cleared.

Reviewed by Dr. Gene, MD · Board-certified Family Medicine
Every Pepti prescription is reviewed by a licensed U.S. physician before it's dispensed — and only provided if clinically appropriate.
How it works in Ohio
- 1Complete a free online intake (~5 minutes).
- 2A licensed Ohio physician reviews your case within 24 hours.
- 3Your prescription ships from our FDA-registered compounding pharmacy.
- 4Free shipping arrives 2–4 business days later. Refills ship automatically when your supply runs out — cancel anytime.
What Tesamorelin (Injectable) does
FDA-studied growth hormone releasing factor analog that targets abdominal fat.
Amounts shown are per unit. Compounded fresh at a US FDA-registered pharmacy.
Quality
Every batch independently tested
Every medication batch dispensed through Pepti is independently tested by a qualified third-party laboratory for applicable quality and safety standards before the pharmacy releases it. Batches are tested to the same standard used by 503B outsourcing facilities.
Sterility
USP <71>Confirms the finished preparation is free of viable microorganisms.
Bacterial endotoxins
USP <85>Screens for endotoxins that can cause fever or inflammatory reactions.
Potency
AssayVerifies the labeled concentration of the active peptide is what is in the vial.
Purity
HPLCChecks the active peptide against impurities and degradation products.
Identity
Mass spectrometryConfirms the peptide in the vial is the correct molecule.
pH
USP <791>Confirms the solution sits within the range specified for injection.
Particulate matter
USP <788>Checks the finished vial for visible and sub-visible particles.
Container closure integrity
USP <1207>Confirms the vial seal holds so sterility is maintained through the beyond-use date.
Recent lots
- Lot 100526-TES-2
Tested 2026-10-07 · Biolink Life Sciences Carolinas
Sterility
Sterile
Endotoxin
<2 EU/mL
Potency
99.4%
- Lot 100526-TES-4
Tested 2026-10-07 · Biolink Life Sciences Carolinas
Sterility
Sterile
Endotoxin
<2 EU/mL
Potency
100.4%
- Lot 092826-TES-2
Tested 2026-09-30 · Biolink Life Sciences Carolinas
Sterility
Sterile
Endotoxin
<2 EU/mL
Potency
99.7%
Telemedicine in Ohio.
Ohio permits telemedicine prescribing under ORC 4731.296. The Ohio State Medical Board allows asynchronous patient-physician relationships for non-controlled medications. Pepti is available in all 50 states and Washington, D.C.
Ohio has one of the highest adult obesity rates in the Midwest, driving substantial GLP-1 demand.
Ohio cities Pepti serves
+ 51 more cities
, Kettering, Elyria, Middletown, Newark, Cuyahoga Falls, Lakewood, Dublin, Euclid, Mansfield, Beavercreek, Mentor, Strongsville, Delaware, Fairfield, Cleveland Heights, Huber Heights, Grove City, Lancaster, Reynoldsburg, Findlay, Warren, Westerville, Hilliard, North Ridgeville, Upper Arlington, Mason, Marion, Gahanna, Brunswick, Lima, Fairborn, Westlake, Stow, Massillon, North Olmsted, North Royalton, Bowling Green, Garfield Heights, Shaker Heights, Marysville, Kent, Green, Wooster, Troy, Avon Lake, Medina, Centerville, Xenia, Avon, Pickerington, PerrysburgYour protocol
How Tesamorelin is prescribed in Ohio.
Who it's for
- Adults with stubborn visceral (abdominal) fat
- Patients pursuing body recomposition under physician supervision
- People who want the strongest growth-hormone release this class of peptide offers
Your physician decides whether Tesamorelin is appropriate for you after reviewing your intake and labs.
Directions & duration
Inject 0.25 mL (25 units) subcutaneously Monday through Friday nights at bedtime.
What's included
- Licensed physician review of your intake, history, and labs
- Medication compounded to your prescription by a PCAB-accredited, FDA-registered pharmacy
- Every batch independently tested before release
- Sterile syringes and alcohol prep pads for injectables
- Tracked delivery to your door, refills on schedule
- Message your physician anytime; dose changes without an appointment
Storage & handling
- Store refrigerated (36–46°F / 2–8°C) at all times, including before first use.
- One vial is your monthly supply. A fresh vial ships to your Ohio address every 28 days on your refill schedule, so you're always well inside the beyond-use date on your label.
- Protect from light. Wipe the stopper with an alcohol pad before every draw.
- Dispose of syringes in the sharps container per the included instructions.
What to expect
A typical course of Tesamorelin in Ohio.
The science
How Tesamorelin works, and what the research shows.
How it works
Tesamorelin is a GHRH analog FDA-studied specifically for visceral fat reduction.
It's the only growth hormone releasing peptide with clinical trial data showing significant reduction in dangerous abdominal fat.
Clinical evidence
Tesamorelin has the strongest human evidence of any GHRH analog: it is FDA-approved (Egrifta) for excess abdominal fat in HIV-associated lipodystrophy, where phase 3 trials showed roughly 15–18% reductions in visceral adipose tissue over 26 weeks.
Falutz et al., N Engl J Med 2007; and subsequent randomized trialsUse outside that indication — including general body-composition protocols — is off-label and decided by the prescribing physician.
References
- Falutz J, Allas S, Blot K et al.. Metabolic effects of a growth hormone-releasing factor in patients with HIV · N Engl J Med (2007) · PMID 18057338
- Stanley TL, Feldpausch MN, Oh J et al.. Effect of tesamorelin on visceral fat and liver fat in HIV-infected patients with abdominal fat accumulation: a randomized clinical trial · JAMA (2014) · PMID 25038357
- Falutz J, Mamputu JC, Potvin D et al.. Effects of tesamorelin (TH9507), a growth hormone-releasing factor analog, in human immunodeficiency virus-infected patients with excess abdominal fat: a pooled analysis of two multicenter, double-blind placebo-controlled phase 3 trials with safety extension data · J Clin Endocrinol Metab (2010) · PMID 20554713
- Falutz J, Potvin D, Mamputu JC et al.. Effects of tesamorelin, a growth hormone-releasing factor, in HIV-infected patients with abdominal fat accumulation: a randomized placebo-controlled trial with a safety extension · J Acquir Immune Defic Syndr (2010) · PMID 20101189
- Stanley TL, Fourman LT, Feldpausch MN et al.. Effects of tesamorelin on non-alcoholic fatty liver disease in HIV: a randomised, double-blind, multicentre trial · Lancet HIV (2019) · PMID 31611038
- Makimura H, Feldpausch MN, Rope AM et al.. Metabolic effects of a growth hormone-releasing factor in obese subjects with reduced growth hormone secretion: a randomized controlled trial · J Clin Endocrinol Metab (2012) · PMID 23015655
- Dal J, Leisner MZ, Hermansen K et al.. Cancer Incidence in Patients With Acromegaly: A Cohort Study and Meta-Analysis of the Literature · J Clin Endocrinol Metab (2018) · PMID 29590449
- Johannsson G, Touraine P, Feldt-Rasmussen U et al.. Long-term Safety of Growth Hormone in Adults With Growth Hormone Deficiency: Overview of 15 809 GH-Treated Patients · J Clin Endocrinol Metab (2022) · PMID 35368070
- Zhou H, Sun L, Zhang S, Wang Y, Wang G. Effect of long-term growth hormone replacement on glucose metabolism in adults with growth hormone deficiency: a systematic review and meta-analysis · Pituitary (2021) · PMID 32888174
- Clemmons DR. Roles of insulin-like growth factor-I and growth hormone in mediating insulin resistance in acromegaly · Pituitary (2002) · PMID 12812310
- Clemmons DR. Consensus statement on the standardization and evaluation of growth hormone and insulin-like growth factor assays · Clinical Chemistry (2011) · PMID 21285256
- Liu H, Bravata DM, Olkin I, Nayak S, Roberts B. Systematic review: the safety and efficacy of growth hormone in the healthy elderly · Annals of Internal Medicine (2007) · PMID 17227934
- Baker LD, Barsness SM, Borson S et al.. Effects of growth hormone-releasing hormone on cognitive function in adults with mild cognitive impairment and healthy older adults: results of a controlled trial · Arch Neurol (2012) · PMID 22869065
Citations are provided for educational purposes. They do not constitute medical advice. Always discuss any peptide protocol with your prescribing physician.
PCAB-accredited pharmacies on every order.
Every fulfillment runs through a PCAB-accredited pharmacy.
See the lab results
- Rigorous third-party quality & safety inspections
- Cleanliness and sterile processes
- Proper ingredient sourcing
- Accurate dosing and formulation
- Staff training and procedures
- Accredited by NABP & ACHC
Frequently asked
about Tesamorelin (Injectable) in Ohio.
Yes. Tesamorelin (Injectable) is legal when prescribed by a physician licensed in Ohio and dispensed by an FDA-registered compounding pharmacy. Ohio permits telemedicine prescribing under ORC 4731.296. The Ohio State Medical Board allows asynchronous patient-physician relationships for non-controlled medications.
Most orders ship from our FDA-registered compounding pharmacy within 1–3 business days after physician approval. Delivery within Ohio typically arrives 1-3 business days after shipment. Pepti serves patients across Ohio including Columbus, Cleveland, Cincinnati, and Toledo.
No. Pepti operates as a fully telehealth platform in Ohio. Ohio permits telemedicine prescribing under ORC 4731.296. The Ohio State Medical Board allows asynchronous patient-physician relationships for non-controlled medications.
Tesamorelin (Injectable) starts at $249 at Pepti. Pepti is subscription-based — your refill ships when your supply runs out, and you can cancel anytime. Pricing is the same nationwide — no Ohio-specific markup. Shipping is free.
Yes — Pepti is available in all 50 states and Washington, D.C. Wherever you are in the country, a physician licensed in your state reviews your intake and your medication ships from an FDA-registered compounding pharmacy.
You don't need an in-person peptide clinic — Pepti provides doctor-prescribed Tesamorelin (Injectable) entirely online anywhere in Ohio. A physician licensed in Ohio reviews your intake, and your medication ships from an FDA-registered compounding pharmacy to your door. Unlike "research use only" peptide sites, every Pepti order requires a valid patient-specific prescription and a licensed dispensing pharmacy.
No. "Research use only" Tesamorelin (Injectable) is sold with no prescription, no physician, and no dispensing pharmacy, and is not legally sold for human use — independent testing of research-grade peptides has repeatedly found underdosing, mislabeling, and contamination. Prescription Tesamorelin (Injectable) is compounded for you at an FDA-registered US pharmacy after a licensed physician's review. When comparing Tesamorelin (Injectable) options in Ohio, only consider providers that can name their prescribing physicians and their dispensing pharmacy.
33 more questions about Pepti, answered.Show fewer
Pepti serves all of Ohio. A physician licensed in Ohio reviews every order within 4 hours, the prescription is compounded by a state-licensed, FDA-registered pharmacy, and it ships free and tracked to any Ohio street address. The price is the same as every other state.
Yes. The whole process is online in Ohio: a free assessment, physician review, messaging, dose changes, and refills through your Pepti account or the Hello Pepti app. No clinic visit is required.
Pepti ships Tesamorelin to Ohio directly from the pharmacy: free, tracked, unbranded, in insulated packaging with ice packs for refrigerated medication. The pharmacy compounds in 1-3 business days and delivery takes 1-3 business days after shipment. PO Boxes are not accepted.
Every treatment on Pepti's catalog ships to Ohio. Eligibility is confirmed during the assessment from your Ohio shipping address, and if anything ever cannot ship to your address it is refunded.
The same as everywhere Pepti serves: one all-in monthly price per treatment that includes the medication, the physician, and shipping, with no Ohio-specific markup and no membership or consult fee. Every price is on the product page.
Yes. Pepti's physicians hold licenses in Ohio, and only a physician licensed where you live reviews and prescribes your order. Their names and credentials are on the providers page.
Yes. Pepti's partner pharmacies are state-licensed, FDA-registered 503A compounding pharmacies licensed to dispense into Ohio, and every batch is independently tested before it ships.
FDA-studied growth hormone releasing factor analog that targets abdominal fat. Tesamorelin is prescription-only at Pepti: a licensed physician reviews your assessment and, if appropriate, prescribes it to be compounded by a state-licensed, FDA-registered pharmacy.
Tesamorelin is commonly prescribed for: Adults with stubborn visceral (abdominal) fat; Patients pursuing body recomposition under physician supervision; People who want the strongest growth-hormone release this class of peptide offers. Whether it is appropriate for you is decided by the reviewing physician from your history, medications, and labs where required.
Yes. Tesamorelin is prescription-only. The free online assessment takes about five minutes, a physician licensed in Ohio reviews it within 4 hours, and if approved the prescription goes to the pharmacy. If not approved, the medication charge is refunded.
Yes. Tesamorelin is one of the medications Pepti requires recent bloodwork for before it is prescribed. Upload a recent lab report from any lab, or order Pepti's at-home panel; the physician reviews the results with your assessment.
Tesamorelin is a subcutaneous injection into the abdomen or thigh with a small insulin syringe. Your kit ships with sterile syringes and alcohol prep pads, and the exact dose and schedule are printed on the pharmacy label. Dosing videos are in your account.
One vial is your monthly supply at the dose your physician prescribes. A fresh vial ships about every 28 days, and the date moves if your physician changes your dose. Store it as the pharmacy label directs, refrigerated.
Once per fill, $249 each time, when the next vial ships. It renews until you cancel, which you can do anytime from your account with no cancellation fee.
The compounded Tesamorelin with sterile syringes and alcohol prep pads, free tracked shipping in an unbranded box with insulated packaging, the physician review, ongoing physician care and dose adjustments, and unlimited messaging.
Reported side effects of Tesamorelin are usually mild: mild redness or swelling at injection site; temporary fatigue or headache; mild nausea (uncommon); joint stiffness (uncommon). The physician screens your history, medications, and allergies before prescribing, the medication-specific consent lists the known risks, and you can message your physician about anything you notice. Seek emergency care for severe symptoms.
Response varies by person, goal, and dose, and Tesamorelin is prescribed for ongoing use rather than a short trial. Your physician sets expectations at approval, tracks how you respond through your account, and adjusts the dose without an appointment.
Yes. Request it from your account or the app; your physician approves or declines. If approved you pay for the additional medication at the pharmacy's cost and the new dose applies to your next shipment.
Yes. Add Tesamorelin to a plan with another treatment and both go through one assessment and one physician review, shipping together on one schedule. Each keeps its own catalog price. The physician reviews the combination and can adjust it.
Compounded Tesamorelin is not FDA-approved. A brand-name form of the active ingredient is FDA-approved for specific indications; Pepti's version is compounded to your physician's prescription by an FDA-registered 503A pharmacy and prescribed off-label.
Yes, when prescribed by a licensed physician and dispensed by a licensed pharmacy, which is how Pepti provides it in Ohio. Research-use-only Tesamorelin sold without a prescription is labeled not for human use and is a different product.
Tesamorelin is a GHRH analog FDA-studied specifically for visceral fat reduction. At Pepti it is prescribed to support visceral fat reduction, gh release, cognitive function, body composition. Individual response varies, and your physician sets expectations at approval.
Tesamorelin is a GHRH analog FDA-studied specifically for visceral fat reduction. It's the only growth hormone releasing peptide with clinical trial data showing significant reduction in dangerous abdominal fat. Compounded Tesamorelin is not FDA-approved; it is prescribed off-label by a licensed physician after reviewing your assessment.
Tesamorelin is prescribed for visceral fat reduction, gh release, cognitive function, body composition. It is commonly requested by adults with stubborn visceral (abdominal) fat; patients pursuing body recomposition under physician supervision; people who want the strongest growth-hormone release this class of peptide offers. Whether it is appropriate for you is the reviewing physician's decision.
Tesamorelin is studied for visceral fat reduction, gh release, cognitive function, body composition. Those are the goals it is prescribed to support at Pepti; results vary by person, dose, and consistency, and no outcome is guaranteed. Your physician tracks how you respond through your account.
Tesamorelin has the strongest human evidence of any GHRH analog: it is FDA-approved (Egrifta) for excess abdominal fat in HIV-associated lipodystrophy, where phase 3 trials showed roughly 15–18% reductions in visceral adipose tissue over 26 weeks (Falutz et al., N Engl J Med 2007; and subsequent randomized trials). Use outside that indication — including general body-composition protocols — is off-label and decided by the prescribing physician. References are listed on this page.
Tesamorelin is generally not prescribed with: active cancer or history of cancer (unless approved by oncologist); pregnancy or breastfeeding; severe kidney or liver disease; known allergy to the peptide or excipients. The physician screens for these in your intake, and anything that rules Tesamorelin out means it is not prescribed and is refunded.
At Pepti. Complete the free assessment, a physician licensed in Ohio reviews it within 4 hours, and if appropriate Tesamorelin is compounded by a state-licensed, FDA-registered pharmacy and shipped free to your door for $249 per month, all-in. Not prescribed means refunded.
Injectable vial: 10 mL at 2 mg/mL, containing 20 mg Tesamorelin. Injectable vial: 5 mL at 6 mg/mL, containing 30 mg Tesamorelin. Injectable vial: 5 mL at 2 mg/mL, containing 10 mg Tesamorelin. One vial is your monthly supply at the prescribed dose, and a fresh one ships about every 28 days.
Not currently. Tesamorelin ships as a multi-dose vial with sterile syringes and prep pads. The pepti Pen is available for 10 other treatments.
$249 per month covers the compounded Tesamorelin, the physician review, ongoing physician care including dose adjustments and refill review, unlimited messaging, and free tracked shipping. There is no membership, consult, visit, or refill fee; the only separate charges are optional at-home lab panels and a physician-approved dose increase billed at pharmacy cost.
Yes. Tesamorelin is on Pepti's live catalog, which lists only treatments a partner pharmacy can compound and ship today. If a physician prescribes it, it ships; if it ever cannot be dispensed, the charge is refunded.
Tesamorelin ships to 50 states, free and tracked, in insulated unbranded packaging. Eligibility is confirmed during the assessment from your shipping address.
Tesamorelin (Injectable) in every state
Pepti is available in all 50 states and Washington, D.C.
Pepti operates in Ohio through licensed physician partnerships. Compounded medications are produced at FDA-registered 503A pharmacies. Treatment decisions are made by your prescribing physician.
